Covishield

Bagaimanapun, suntikan yang telah diberikan kepada jutaan rakyat Britain itu masih belum dipersetujui Agensi Ubat-Ubatan Eropah (EMA).

India began an inoculation drive for its 1.38 billion people in earnest in mid-January.

Here are some of the most notable and bizarre inducements on offer.

India's COVID-19 tally rose to 26,289,290 with 257,299 new cases registered in the past 24 hours, said the federal Ministry of Health and Family Welfare on Saturday.

India is currently administering AstraZeneca's COVID-19 vaccine, manufactured by SII and delevoped by Bharat Biotech called COVAXIN.

The south Asian country is seeking to inoculate 80% of its population of around 170 million.

India's huge coronavirus vaccination drive is behind schedule, hampered by technical glitches and safety fears.

Unlike the rival Pfizer-BioNTech vaccine, Covishield can be stored and transported using standard refrigeration.

Many low and middle-income countries are relying on India, for supplies to start COVID-19 immunisation programmes.

Leading scientists and doctors have called on authorities to release efficacy data about Covaxin to boost confidence about the vaccine.

Here are the latest developments in the coronavirus crisis.

Kerajaan India menyasarkan seramai 300 juta orang divaksinkan dalam tempoh enam hingga lapan bulan pertama tahun ini.

Looking forward to the weekend ahead? But first, have a listen to today's headlines in just 3-minutes.

Penghantaran pertama vaksin yang mengandungi vaksin COVISHIELD yang dihasilkan Serum Institute of India serta dibangunkan Universiti Oxford dan AstraZeneca meninggalkan bandar Pune pada Selasa.

COVID-19 cases rose by 12,584 on Tuesday - the lowest daily increase in several months - to 10.48 million.